Illumina, Inc.

$80$125

The company engaged in array-based and sequencing solutions for genomic and genetic analysis. The Company’s offering serves wide range of market area, enabling the adoption of genomic product and solutions in clinical and research settings. The Company’s customers include academic institutions, leading genomic research centers, leading genomic research centers, government laboratories, and hospitals, as well as biotechnology, pharmaceutical, commercial molecular diagnostic laboratories, and consumer genomics companies. The company is offering wide range of portfolio of integrated microarray and sequencing systems, consumables, and analysis tools and devices which is designed to simplify and accelerate genetic analysis

Report ID:

UMHE21185

Published:

Jan-2022

Pages:

14

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21185 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Value, Product Portfolio, and Business Headquarter
Information on its recent developments including collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Value
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    Executive Team
8.    SWOT Analysis
9. Company Revenue Split
10.    Key Financials
11. Recent Developments
11.1 Product Launches
11.2 Partnerships
11.3 Mergers and Acquisitions”

Companies Mentioned

“Roche
QIAGEN N.V.
Bristol-Myers Squibb
Pacific Biosciences
GRAIL
Edico Genome”